BeStock  
Stocks › Biotechnology › ABVX

Abivax S.A. ABVX

US equityMarket cap rank #1799Biotechnology
$73.20 −$7.45 (-9.24%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $74.95 +2.39%
Open$79.01
Prev close$80.65
Day range$62.70 – $79.74
Volume14.85M
Market cap$6.41B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026 · reported in EUR

Revenue€0.00
Operating profit-€84.11M-80.9% YoY
Net profit-€117.43M-142.6% YoY
Diluted EPS-€1.47-93.4% YoY
Free cash flow-€52.10M-56.2% YoY
Operating cash flow-€51.99M

Revenue, last 8 quarters

€0.0Sep '24€0.0Dec '24€0.0Mar '25€0.0Jun '25€0.0Sep '25€0.0Dec '25€0.0Mar '26€0.0Jun '26

Net profit, last 8 quarters

€-55.2MSep '24€-39.4MDec '24€-52.4MMar '25€-48.4MJun '25€-153.4MSep '25€-82.0MDec '25€-48.5MMar '26€-117.4MJun '26

Diluted EPS by quarter

-0.87Sep '24-0.63Dec '24-0.83Mar '25-0.76Jun '25-2.10Sep '25-1.02Dec '25-0.61Mar '26-1.47Jun '26

Free cash flow by quarter

€-35.7MSep '24€-33.6MDec '24€-33.3MMar '25€-33.4MJun '25€-71.3MSep '25€-23.3MDec '25€-50.6MMar '26€-52.1MJun '26

Annual revenue

€0.0FY20€0.0FY21€0.0FY22€0.0FY23€0.0FY24€0.0FY25

Profitability & balance sheet

Return on equity-252.3%
Return on assets-137.9%
Return on invested capital-190.2%
Current ratio5.97
Liabilities / assets20.8%
Cash & investments€410.68M
Total debt€137,000.00
Net cash (debt)€410.55M

This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.

Income statement

Line item 2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
2025 Q3
(EUR)
Total Operating Revenue €0.00 €0.00 €0.00 €0.00 €0.00
Operating Expense €84.11M €56.23M €246.06M €71.65M €80.71M
Selling and Admin Expenses €26.98M €8.03M €72.87M €27.69M €27.34M
-Selling & Marketing Expense €102,000.00 €75,000.00 €224,000.00 €21,000.00 €14,000.00
-General & Admin Expense €26.87M €7.96M €72.64M €27.67M €27.33M
Research & Development €58.34M €49.54M €177.76M €44.40M €55.42M
Other Operating Expenses -€1.20M -€1.34M -€4.57M -€440,000.00 -€2.04M
Operating Profit -€84.11M -€56.23M -€246.06M -€71.65M -€80.71M
Net Non-Operating Interest Income (Expense) €2.69M €1.50M -€52.49M €1.22M -€49.14M
Non-Operating Interest Income €1.28M €769,000.00 €5.75M €807,000.00 €3.53M
Non-Operating Interest Expense €730,000.00 €2.54M €28.48M €15.27M €4.21M
Total Other Finance Costs -€2.14M -€3.27M €29.76M -€15.68M €48.46M
Other Income (Expense) -€42.09M €6.49M -€31.71M -€5.68M -€23.50M
Gain on Sale of Security €1.12M €6.49M -€27.87M -€1.84M -€23.50M
Special Income (Charges) -€43.21M – -€3.84M – –
-Less:Other Special Charges €43.21M – €3.84M – –
Pretax Profit -€123.51M -€48.24M -€330.25M -€76.11M -€153.36M
Tax -€6.08M €228,000.00 €5.85M €5.85M €0.00
Net Profit -€117.43M -€48.47M -€336.10M -€81.96M -€153.36M
Profit from Continuing Operations -€117.43M -€48.47M -€336.10M -€81.96M -€153.36M
Net Income to Parent Company -€117.43M -€48.47M -€336.10M -€81.96M -€153.36M
Net Income to Common Stockholders -€117.43M -€48.47M -€336.10M -€81.96M -€153.36M
Basic EPS -€1.47 -€0.61 -€4.83 -€1.02 -€2.10
Diluted EPS -€1.47 -€0.61 -€4.83 -€1.02 -€2.10

Balance sheet

Line item 2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
2025 Q3
(EUR)
Total Assets €462.21M €547.14M €584.34M €584.34M €652.05M
Total Current Assets €427.62M €513.22M €551.24M €551.24M €619.30M
Cash and Cash Equivalents & Short-Term Investments €410.68M €491.55M €530.38M €530.38M €589.70M
-Cash and Cash Equivalents €387.99M €477.42M €516.69M €516.69M €589.70M
-Short Term Investments €22.69M €14.13M €13.70M €13.70M –
Receivables €12.42M €10.81M €10.50M €10.50M €19.66M
-Notes Receivable €243,000.00 – €0.00 €0.00 €11,000.00
-Taxes Receivable €11.31M €10.62M €10.07M €10.07M €13.06M
-Other Receivables €872,000.00 €190,000.00 €429,000.00 €429,000.00 €6.59M
Prepaid Assets €4.39M €10.86M €10.37M €10.37M €9.93M
Other Current Assets €125,000.00 -€1,000.00 – – -€1,000.00
Total Non-Current Assets €34.59M €33.92M €33.10M €33.10M €32.76M
Net PPE €1.52M €1.78M €2.09M €2.09M €1.91M
-Gross PPE €4.46M €4.34M €4.27M €4.27M €3.92M
-Accumulated Depreciation -€2.94M -€2.56M -€2.18M -€2.18M -€2.00M
Non Current Accounts Receivables €2.14M €1.14M – – –
Non-Current Prepaid Assets €5.90M €5.98M €5.98M €5.98M €5.69M
Goodwill and Other Intangible Assets €25.02M €25.02M €25.02M €25.02M €25.02M
-Goodwill €18.42M €18.42M €18.42M €18.42M €18.42M
-Other Intangible Assets €6.61M €6.61M €6.61M €6.61M €6.61M
Total Liabilities €95.94M €117.55M €129.14M €129.14M €140.81M
Total Current Liabilities €71.69M €62.23M €63.02M €63.02M €78.76M
Payables €21.28M €12.26M €44.69M €44.69M €17.63M
-Accounts Payable €18.26M €9.96M €37.55M €37.55M €14.36M
-Total Tax Payable €177,000.00 €164,000.00 €7.14M €7.14M €259,000.00
-Other Payable €2.84M €2.13M – – €3.02M
Current Accrued Expenses €20.75M €19.55M – – €15.66M
Short-Term Debt and Capital Lease Obligation €1.08M €1.10M €1.30M €1.30M €29.40M
-Current Capital Lease Obligation €1.08M €1.10M €1.30M €1.30M €938,000.00
Current Provisions €23.91M €18.13M €17.03M €17.03M €11.41M
Total Non-Current Liabilities €24.25M €55.32M €66.12M €66.12M €62.05M
Long Term Debt and Capital Lease Obligation €137,000.00 €346,000.00 €554,000.00 €554,000.00 €16.49M
-Long Term Capital Lease Obligation €137,000.00 €346,000.00 €554,000.00 €554,000.00 €611,000.00
Non-Current Liabilities €23.42M €15.49M €28.85M €28.85M €16.62M
Non-Current Deferred Liabilities €0.00 €6.08M €5.85M €5.85M –
Employee Benefits €696,000.00 €638,000.00 €627,000.00 €627,000.00 €844,000.00
Other Non-Current Liabilities -€1,000.00 €32.76M €30.24M €30.24M €28.10M
Total Equity €366.27M €429.59M €455.21M €455.21M €511.24M
Stockholders' Equity €366.27M €429.59M €455.21M €455.21M €511.24M
Capital Stock €798,000.00 €793,000.00 €785,000.00 €785,000.00 €778,000.00
-Common Stock €798,000.00 €793,000.00 €785,000.00 €785,000.00 €778,000.00
Additional Paid-In Capital €1.23B €1.19B €1.19B €1.19B €1.18B
Retained Earnings -€864.96M -€764.31M -€738.48M -€738.48M -€669.81M
Gains/Losses Not Affecting Retained Earnings €1.77M €2.03M €2.31M €2.31M €743,000.00
Other Non-Current Assets – €1,000.00 -€1,000.00 -€1,000.00 –
Investments and Advances – – €0.00 €0.00 €126,000.00
Current Deferred Liabilities – – €0.00 €0.00 –
Derivative Product Liabilities – – €0.00 €0.00 €0.00
-Available for Sale Securities – – – – €126,000.00
-Current Debt – – – – €28.46M
-Long Term Debt – – – – €15.88M

Cash flow

Line item 2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
2025 Q3
(EUR)
Operating Cash Flow -€51.99M -€50.52M -€161.13M -€23.23M -€71.28M
Net cash flow from continuing operations -€51.99M -€50.52M -€161.13M -€23.23M -€71.28M
Net Income from Continuing Operations -€117.43M -€48.47M -€336.10M -€81.96M -€153.36M
Gain/Loss from Continuing Operations €31,000.00 €34,000.00 €62.27M -€171,000.00 €63.29M
Depreciation & Depletion & Amortization €374,000.00 €367,000.00 €1.07M €276,000.00 €272,000.00
Deferred Tax -€6.08M €228,000.00 €5.85M – –
Other Non-Cash Items €39.43M -€7.98M €22.03M €4.91M €9.11M
Change in Working Capital €1.24M -€4.98M €3.65M -€9.73M -€2.08M
-Change in Receivables -€1.54M -€3.48M €7.04M €9.34M -€4.59M
-Change in Payables and Accrued Expense €2.85M -€1.49M -€4.10M €6.73M -€23.26M
Net cash flow from investing €971,000.00 €495,000.00 -€8.19M -€12.74M €3.28M
Net Cash Flow from Continuing Investing Activities €971,000.00 €495,000.00 -€8.19M -€12.74M €3.28M
Net PPE Purchase and Sale -€112,000.00 -€54,000.00 -€142,000.00 -€87,000.00 €8,000.00
Net Business Purchase and Sale €6,000.00 €37,000.00 – – €40,000.00
Financing Cash Flow -€39.35M €73,000.00 €547.31M -€39.55M €603.46M
Net Cash Flow from Continuing Financing Activities -€39.35M €73,000.00 €547.31M -€39.55M €603.46M
Net Issuance Payments Of Debt -€104,000.00 -€389,000.00 -€59.53M -€40.76M -€5.74M
Cash Dividends Paid €0.00 €0.00 €0.00 €0.00 €0.00
Ending Cash Balance €387.99M €477.42M €516.69M €516.69M €589.70M
Net Change in Cash -€84.95M -€49.95M €382.72M -€71.71M €535.91M
Beginning Cash Balance €477.42M €516.69M €144.22M €589.70M €60.95M
Effect of Exchange Rate Changes -€4.48M €10.69M -€10.25M -€1.31M -€7.16M
Free Cash Flow -€52.10M -€50.57M -€161.27M -€23.32M -€71.28M
Net Investment Purchase and Sale – €0.00 – – –
Proceeds from Stock Option Exercised – €475,000.00 €5.82M €3.15M –
-Change In Other Working Capital – – €710,000.00 -€25.81M €25.77M
Net Intangibles Purchase and Sale – – €0.00 €0.00 –
Net Other Investing Changes – – -€13.58M -€13.47M -€224,000.00
Net Common Stock Issuance – – €648.12M €40.04M –
Net Other Financing Charges – – -€40.61M -€40.92M €1,000.00

Discussion

No comments yet — be the first to weigh in on ABVX.

Sign in to join the discussion.

Scroll to Top